These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
396 related items for PubMed ID: 7270421
1. Pharmaceutical analysis: key to drug quality and control. Florey KG, Brewer GA. Am Pharm; 1981 Aug; NS21(8):30-5. PubMed ID: 7270421 [No Abstract] [Full Text] [Related]
2. Report on the PQRI impurity characterization and quantification best practices survey. Faustino P, Chan CC, Carrano J, Gosnell M, Gu ZQ, Maule A, Sigvardson K, Zhang YF. Pharm Res; 2006 Feb; 23(2):440-6. PubMed ID: 16477396 [No Abstract] [Full Text] [Related]
4. The potential impact of usp general chapter <797> on procedures and requirements for the preparation of sterile radiopharmaceuticals. Hung JC. J Nucl Med; 2004 Jun; 45(6):21N-6N. PubMed ID: 15181115 [No Abstract] [Full Text] [Related]
5. Standardization of forensic drug analyses. Frank RS, Gunn JW. J Forensic Sci; 1974 Jan; 19(1):163-7. PubMed ID: 4854386 [No Abstract] [Full Text] [Related]
6. Assuring total drug quality. Simmons HE. J Am Pharm Assoc; 1973 Feb; 13(2):96-8. PubMed ID: 4686621 [No Abstract] [Full Text] [Related]
7. [Control of drugs in foreign countries]. Buriánek J, Parrák V. Cesk Farm; 1973 Jul; 22(6):247-53. PubMed ID: 4732551 [No Abstract] [Full Text] [Related]
8. How good are our drugs? Miller LC. Am J Hosp Pharm; 1970 May; 27(5):367-74. PubMed ID: 5422276 [No Abstract] [Full Text] [Related]
9. Relationship of USP-NF to NDA and ANDA "Standards". Belson JJ. Am J Hosp Pharm; 1982 May; 39(5):869-70. PubMed ID: 7081269 [No Abstract] [Full Text] [Related]
11. Public standards for drugs: reflections on their use by the professions and industry. Miller LC. Hosp Formul; 1976 Mar; 11(3):151-5. PubMed ID: 1026682 [No Abstract] [Full Text] [Related]
12. Drug product equivalence--the problem, the challenge, and the U.S.P. Macek TJ. Am J Pharm Sci Support Public Health; 1971 Mar; 143(6):188-94. PubMed ID: 5140167 [No Abstract] [Full Text] [Related]
13. WHO Expert Committee on Specifications for Pharmaceutical Preparations. Thirty-first report. World Health Organ Tech Rep Ser; 1990 Mar; 790():1-79. PubMed ID: 2110393 [No Abstract] [Full Text] [Related]
14. [Pharmacopeia and preparations for cutaneous application]. Esnault F, Etchegaray JP, Mallard C. Ann Dermatol Venereol; 2007 Mar; 134(3 Pt 2):2S40-5. PubMed ID: 17563714 [No Abstract] [Full Text] [Related]
15. Keeping watch on drug quality. Furman WB. FDA Consum; 1975 Oct; 9(8):18-23. PubMed ID: 10316632 [No Abstract] [Full Text] [Related]
16. Controlling the quality of Uncle Sam's drugs. Hecht A. FDA Consum; 1977 May; 11(4):22-3. PubMed ID: 10316531 [No Abstract] [Full Text] [Related]
17. [Analytical and technological control of some official preparations]. Pirisino G, Piu L. Boll Chim Farm; 1978 May; 117(5):296-302. PubMed ID: 743378 [No Abstract] [Full Text] [Related]
18. Drug Product Problem Reporting Program. FDA Drug Bull; 1979 Aug; 9(3):18. PubMed ID: 467875 [No Abstract] [Full Text] [Related]
19. Assuring the quality of the nation's drugs. Interview by William E. Small. Michels D. Am Pharm; 1980 Apr; NS20(4):40-2. PubMed ID: 7386377 [No Abstract] [Full Text] [Related]
20. Improving drug quality through certification experience. Weiss PJ. Am J Pharm Sci Support Public Health; 1974 Apr; 146(3):86-90. PubMed ID: 4852375 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]